CANY
NOTV

Caxton Associates (New York)’s Inotiv NOTV Stock Holding History

Caxton Associates (New York)’s Portfolio NOTV Stock Details NOTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,588
Closed -$572K – 646
2021
Q4 		$572K Buy
+13,588
New +$608K 0.06% 247

Other funds holding NOTV

PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Caxton Associates (New York)'s NOTV Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Inotiv (NOTV) in Q1 2022, closing a stake of 13,588 shares — an estimated $572K sold.

Caxton Associates (New York) first reported a position in NOTV in Q4 2021 and held it in 1 quarter. The position peaked at $572K in Q4 2021. 97 funds tracked by Wall St. Rank hold NOTV as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Inotiv position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 13,588 Inotiv shares in Q1 2022, an estimated $572K.
  • Caxton Associates (New York) first reported a position in Inotiv in Q4 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Inotiv position peaked at $572K in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Inotiv as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.